Sentences with phrase «major pharma companies»

The good news is, the number of pharma sales jobs posted appears to be rebounding, and Forbes reports a surprising 10,000 pharma job openings at 10 major pharma companies.

This week, the FTC published a report that claims that these settlements result in substantial extra delay in getting generic products into the market; and the European Commission requested information on the deals from several major pharma companies.

PsychoGenics has pioneered the translation of rodent behavioral responses into robust, high throughput, high content phenotyping and its drug discovery platforms, SmartCube ®, NeuroCube ®, and PhenoCube ® have led to shared risk partnerships with major pharma companies such as Sunovion and Roche and resulted in the discovery of several novel compounds now in clinical trials or advanced preclinical development.

The «microbiome,» or the collection of organisms that reside within the human body (especially the gut), has become a big new interest area for a number of major pharma companies like Merck and smaller biotechs alike.

At that price, he would collect $ 800 million, or $ 200 million a year over four years — making more than the CEOs of more than a dozen major pharma companies are likely to be paid, combined.

President Donald Trump sat down with a host of major pharma company CEOs Tuesday morning to address pressing issues like high drug prices, the future of the FDA, and where treatments are produced.

Not exact matches

Unlike many upstart pharma companies that must turn to the financial markets for expansion dollars, Prollenium's sales volume provided the cash it needed to finance new research and development, as well as a major capital project.

Common Cause says the Moreland Commission should open a probe to see if there's a link between around $ 5 million spent by major pharmaceutical companies on lobbying and campaign donations to New York state politicians, and the failure to pass major consumer - friendly bills regulating Big Pharma.

Big pharma and companies that produce everything from tinned beans to toothpaste are major employers of chemists, but it can pay to look beyond these giants.

Table 1: Selection, Design & Construction of HSV - based Oncolytic Viruses Table 2: Selection, Design & Construction of Adenovirus - based Oncolytic Viruses Table 3: Selection, Design & Construction of Vaccinia Virus - based Oncolytic Viruses Table 4: Selection, Design & Construction of Vesicular Stomatitis Virus - based Oncolytic Viruses Table 5: Selection, Design & Construction of Newcastle Disease Virus - based Oncolytic Viruses Table 6: Selection, Design & Construction of Various Virus - based Oncolytic Viruses Table 7: Current Company - Sponsored Clinical Trials of T - Vec Table 8: Clinical Trials of ColoAd1 Table 9: Clinical Trials with JX - 594 Table 10: Clinical Trials with GL - ONC1 Table 11: Clinical Trials of CAVATAK (CVA21) Table 12: Clinical Trials with MV - NIS Table 13: Overview of Oncolytic Viruses by Development Phase & Virus Family Table 14: Profile of Approved and Marketed Oncolytic Viruses Table 15: Pivotal Study Design of Oncolytic Viruses in Late Stage Development Based on Previous Clinical Results Table 16: Approved Indications of Immune Checkpoint Inhibitors Table 17: Active Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 18: Planned Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 19: Active or Planned Clinical Studies of Oncolytic Viruses in Combination with Other Anti-Cancer Therapeutics Table 20: Pattern of Transgenes in Oncolytic Viruses in Relation to Development Phase Tables 21a and 21b: Indications and Frquency and Way of Administration of Oncolytic Viruses in Active and / or Positive Completed Clinical Studies Table 22: Small and Medium Pharma & Biotech as Partner for Regional Co-Development of Oncolytic Viruses Table 23: Immuno - Oncology Portfolio of Major Pharma & Biotech with Interest in Oncolytic Viruses Table 24: Interests of Major Pharma & Biotech in Oncolytic Viruses Table 25: First Generation Oncology Virus Companies and their Sources of Technology Table 26: Second Generation Oncology Virus Companies and their Sources of Technology Table 27: Third Generation Oncology Virus Companies and their Sources of Technology Table 28: Fourth Generation Oncology Virus Companies and their Sources of Technology Table 29: Grants, Credits & Donations Table 30: Financing by Venture Capital, Private Equity and Other Private Placements Table 31: Collaboration & Licensing Agreements Table 32: Companies Listed on Stock Exchange & Offerings Table 33: Mergers & Acquisitions

She has worked closely with top pharma majors and healthcare companies to build and execute strategies for HCP and patient engagement.

Sackler, a Greenwich resident whose company, Purdue Pharma, makes OxyContin, is Connecticut's leading pro-charter school advocate, having founded and funded Connecticut's major Corporate Education Reform Industry advocacy groups including ConnCAN, ConnAD and A Better Connecticut.

It will also have global implications for biotech and pharma companies, shaping two major industry trends:

Ideal Companies: Major Pharma Manufacturer, Medical Supply Manufacturer, University, Teaching Hospital, Regional Medical Center, Psychiatric Hospital, Government,